MONTE ROSA THERAPEUTICS INC. - COMMON STOCK

Monte Rosa Therapeutics to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

22 11 2021 07:30:00 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces First Development Candidate and Reports Third Quarter 2021 Financial Results and Business Updates

10 11 2021 07:30:01 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present at 4th Annual Targeted Protein Degradation Summit

20 10 2021 07:30:00 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics Presents Preclinical Data at AACR-NCI-EORTC Highlighting Potential of Molecular Glue Degraders for the Treatment of Myc-driven Cancer

07 10 2021 09:00:02 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Present Late-breaking Preclinical Data on Targeting GSPT1 for Myc-driven Cancers at AACR-NCI-EORTC Virtual International Conference

30 9 2021 16:30:00 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces Addition to Russell 2000® and Russell 3000® Indexes

10 9 2021 07:30:00 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics to Participate in Morgan Stanley 19th Annual Global Healthcare Conference

08 9 2021 07:30:00 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress

12 8 2021 07:30:00 提供 Nasdaq GlobeNewswire

Monte Rosa Therapeutics Announces Pricing of Initial Public Offering

23 6 2021 20:20:00 提供 Nasdaq GlobeNewswire